IA
IRMD icon

IFP Advisors’s iRadimed IRMD Stock Holding History

IFP Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.4K Buy
569
+413
+265% +$37.6K ﹤0.01% 2348
2026
Q1 		$15K Sell
156
-47
-23% -$4.7K ﹤0.01% 2937
2025
Q4 		$19.7K Sell
203
-24
-11% -$2.06K ﹤0.01% 2731
2025
Q3 		$16.2K Buy
227
+102
+82% +$6.8K ﹤0.01% 2693
2025
Q2 		$7.47K Buy
125
+58
+87% +$3.18K ﹤0.01% 3093
2025
Q1 		$3.52K Buy
67
+66
+6,600% +$3.71K ﹤0.01% 2965
2024
Q4 		$55 Buy
+1
New +$53 ﹤0.01% 4230
2017
Q4 		– Sell
-150
Closed -$1K – 3946
2017
Q3 		$1K Hold
150
– – ﹤0.01% 3914
2017
Q2 		$1K Buy
+150
New +$1.28K ﹤0.01% 3895

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IFP Advisors's IRMD Position: Q2 2026 in Review

IFP Advisors increased its iRadimed (IRMD) stake by 265% in Q2 2026, buying an estimated $37.6K and bringing the position to 569 shares worth $54.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

IFP Advisors first reported a position in IRMD in Q2 2017 and has held it in 9 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • IFP Advisors held 569 shares of iRadimed worth $54.4K as of Q2 2026.
  • IFP Advisors bought 413 iRadimed shares in Q2 2026, an estimated $37.6K.
  • iRadimed made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2348 holding.
  • IFP Advisors first reported a position in iRadimed in Q2 2017 and has held it in 9 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.